Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With a legacy of innovation since 1899 Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical needs. For more information, please visit www.daiichi-sankyo.be
| Website | http://www.daiichi-sankyo.be |
| Revenue | $15.4 million |
| Employees | 55 (48 on RocketReach) |
| Founded | 1899 |
| Phone | (321) 048-9595 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Research, Innovative Therapies, Drug Development, Drug Discovery, Clinical Trials, Medicine Manufacturing, Biotechnology, Medical Science, Medical Technology, Healthcare, Global Health, Patient Care, Pharmaceutical Sales, Oncology, Cardiology, Immunology, Regulatory Affairs, Neurology, Rare Diseases |
| Competitors | Roche, Pfizer, Boehringer Ingelheim, Bristol Myers Squibb, AstraZeneca, Novartis, Johnson & Johnson, Sanofi, GSK, Merck AH +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Daiichi Sankyo Belgium employee's phone or email?
Daiichi Sankyo Belgium Questions
The Daiichi Sankyo Belgium annual revenue was $15.4 million in 2026.
Koen Vaes is the Finance Director BeLux of Daiichi Sankyo Belgium.
48 people are employed at Daiichi Sankyo Belgium.
The NAICS codes for Daiichi Sankyo Belgium are [325, 32].
The SIC codes for Daiichi Sankyo Belgium are [283, 28].
Top Daiichi Sankyo Belgium Employees
-
Koen Vaes
Finance Director BeLux at Daiichi Sankyo Belgium
Basse-Wavre, BE22 -
11
Related Companies
